Zdrowie i gospodarka · 21/06/2000

FDA Announces Draft Guidance for Pediatric Oncology Studies in Response to Written Request

The FDA has released a draft guidance document to help pharmaceutical companies prepare pediatric studies for a potential new cancer treatment, which could qualify for an additional 6 months of marketing exclusivity if approved.